Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Krystal Biotech, Inc. (KRYS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Krystal Biotech, Inc. (KRYS), most recent 12 months reported: revenue $440.48M, net income $241.47M, free cash flow $257.78M. Latest balance sheet on file: liquid cash $845.63M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): BIOCRYST PHARMACEUTICALS, INC. · REPLIGEN CORP · TARSUS PHARMACEUTICALS, INC. · ADMA BIOLOGICS, INC. · Twist Bioscience Corporation · Immunocore Holdings plc · NOVAVAX INC · MeiraGTx Holdings plc

Stock screener

Watchlist